pcDNA3.1-VcnCS-E1015A-E1021A
(Plasmid
#213414)
-
PurposeVinculin conformation sensor (VcnCS) with both directionally asymmetric, force strengthening (DAFS) variant point mutations (E1015A and E1021A).
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 213414 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA3.1
- Backbone size w/o insert (bp) 5333
- Total vector size (bp) 9991
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameVcnCS-E1015A-E1021A
-
Alt nameVinCS-E1015A-E1021A
-
Alt nameVinculinCS-E1015A-E1021A
-
SpeciesG. gallus (chicken), Synthetic
-
Insert Size (bp)4658
-
MutationMutated vinculin glutamic acid 1015 and 1021 to alanine (E1015A and E1021A)
-
Entrez GeneVCL (a.k.a. VINC1)
- Promoter CMV
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site HindIII (not destroyed)
- 3′ cloning site XbaI (not destroyed)
- 5′ sequencing primer CMV Forward
- 3′ sequencing primer BGH Reverse (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pcDNA3.1-VcnCS-E1015A-E1021A was a gift from Brenton Hoffman (Addgene plasmid # 213414 ; http://n2t.net/addgene:213414 ; RRID:Addgene_213414) -
For your References section:
Molecular basis and cellular functions of vinculin-actin directional catch bonding. Chirasani VR, Khan MAI, Malavade JN, Dokholyan NV, Hoffman BD, Campbell SL. Nat Commun. 2023 Dec 14;14(1):8300. doi: 10.1038/s41467-023-43779-x. 10.1038/s41467-023-43779-x PubMed 38097542